General Information of the Compound
Compound ID
CP0532349
Compound Name
5-(1-benzyltetrazol-5-yl)quinoline
    Show/Hide
Structure
Formula
C17H13N5
Molecular Weight
287.326
Canonical SMILES
C(c1ccccc1)n1nnnc1-c1cccc2ncccc12
    Show/Hide
InChI
InChI=1S/C17H13N5/c1-2-6-13(7-3-1)12-22-17(19-20-21-22)15-8-4-10-16-14(15)9-5-11-18-16/h1-11H,12H2
    Show/Hide
InChIKey
XJVQQGZQGTYURA-UHFFFAOYSA-N
Physicochemical Property
logP
2.9366
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
56.49
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11644924
SID: 16748269
ChEMBL ID
CHEMBL210834
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 15848.93 nM
   TI
   LI
   LO
   TS